157 related articles for article (PubMed ID: 22652548)
1. Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide.
Hsiao MH; Larsson M; Larsson A; Evenbratt H; Chen YY; Chen YY; Liu DM
J Control Release; 2012 Aug; 161(3):942-8. PubMed ID: 22652548
[TBL] [Abstract][Full Text] [Related]
2. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs.
Huang WC; Hu SH; Liu KH; Chen SY; Liu DM
J Control Release; 2009 Nov; 139(3):221-8. PubMed ID: 19607866
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system.
Lee J; Lee C; Kim TH; Lee ES; Shin BS; Chi SC; Park ES; Lee KC; Youn YS
J Control Release; 2012 Aug; 161(3):728-34. PubMed ID: 22634071
[TBL] [Abstract][Full Text] [Related]
4. Optimization of in vitro release of an anticonvulsant using nanocapsule-based thermogels.
Esmaeili A; Singh S
Eur J Pharm Sci; 2017 Mar; 99():9-16. PubMed ID: 27940081
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery.
Meng L; Huang W; Wang D; Huang X; Zhu X; Yan D
Biomacromolecules; 2013 Aug; 14(8):2601-10. PubMed ID: 23819825
[TBL] [Abstract][Full Text] [Related]
6. Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery system.
Liu L; Tang X; Wang Y; Guo S
Int J Pharm; 2011 Jul; 414(1-2):6-15. PubMed ID: 21554937
[TBL] [Abstract][Full Text] [Related]
7. Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
Kempe S; Metz H; Bastrop M; Hvilsom A; Contri RV; Mäder K
Eur J Pharm Biopharm; 2008 Jan; 68(1):26-33. PubMed ID: 17870449
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules.
Zhang W; Gilstrap K; Wu L; K C RB; Moss MA; Wang Q; Lu X; He X
ACS Nano; 2010 Nov; 4(11):6747-59. PubMed ID: 21038924
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
Ho EA; Vassileva V; Allen C; Piquette-Miller M
J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of chitosan-based nanogels/gels for oral delivery of myricetin.
Yao Y; Xia M; Wang H; Li G; Shen H; Ji G; Meng Q; Xie Y
Eur J Pharm Sci; 2016 Aug; 91():144-53. PubMed ID: 27328876
[TBL] [Abstract][Full Text] [Related]
12. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer.
Kim S; Nishimoto SK; Bumgardner JD; Haggard WO; Gaber MW; Yang Y
Biomaterials; 2010 May; 31(14):4157-66. PubMed ID: 20185170
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities.
Wang Z; Ho PC
Small; 2010 Nov; 6(22):2576-83. PubMed ID: 20976704
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H
Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237
[TBL] [Abstract][Full Text] [Related]
16. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU).
Depani BP; Naik AA; Nair HA
Acta Pharm; 2013 Dec; 63(4):479-91. PubMed ID: 24451073
[TBL] [Abstract][Full Text] [Related]
18. Reconstituted spray-dried phenytoin-loaded nanocapsules improve the in vivo phenytoin anticonvulsant effect and the survival time in mice.
de Oliveira EG; Cardoso AM; Paese K; Coradini K; de Oliveira CV; Pohlmann AR; Oliveira MS; Guterres SS; Beck RCR
Int J Pharm; 2018 Nov; 551(1-2):121-132. PubMed ID: 30218826
[TBL] [Abstract][Full Text] [Related]
19. Hydrophobic amino acids grafted onto chitosan: a novel amphiphilic chitosan nanocarrier for hydrophobic drugs.
Motiei M; Kashanian S; Taherpour AA
Drug Dev Ind Pharm; 2017 Jan; 43(1):1-11. PubMed ID: 27802776
[TBL] [Abstract][Full Text] [Related]
20. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
